Release Date: 09/03/16 07:51 Summary: New CEO appointed for TransGrid Price Sensitive: No Download Document 49.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%